PulmCCM

PulmCCM

Restricting blood transfusion in patients with myocardial infarction and anemia (MINT trial)

PulmCCM's avatar
PulmCCM
Jan 07, 2024
∙ Paid

In randomized trials totaling over 21,000 patients, restricting red blood cell transfusion until hemoglobin fell below 7 or 8 g/dL in acutely ill, hemodynamically stable patients (as compared to transfusing below 9 or 10 g/dL) resulted in a 50% reduction in blood transfused, without apparent harm.

In critically ill patients, the 1999 TRICC trial establi…

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PulmCCM LLC · Publisher Terms
Substack · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture